We are live on ! Find out more
EXAS

Exact Sciences

Delisted

EXAS was delisted on the 20th of March, 2026.

370 hedge funds and large institutions have $7.08B invested in Exact Sciences in 2018 Q4 according to their latest regulatory filings, with 74 funds opening new positions, 93 increasing their positions, 130 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more funds holding in top 10

Funds holding in top 10: 710 (+3)

12% more first-time investments, than exits

New positions opened: 74 | Existing positions closed: 66

1% more funds holding

Funds holding: 365370 (+5)

1.73% less ownership

Funds ownership: 93.36%91.63% (-1.7%)

22% less capital invested

Capital invested by funds: $9.04B → $7.08B (-$1.96B)

28% less repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 130

38% less call options, than puts

Call options by funds: $246M | Put options by funds: $400M

Holders
370
Holders Change
+5
Holders Change %
+1.37%
% of All Funds
8.24%
Holding in Top 10
10
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+42.86%
% of All Funds
0.22%
New
74
Increased
93
Reduced
130
Closed
66
Calls
$246M
Puts
$400M
Net Calls
-$154M
Net Calls Change
+$302M
Name Holding Trade Value Shares
Change
Change in
Stake
Walleye Trading
126
Walleye Trading
New York
$4.23M +$4.6M +66,984 New
Creative Planning
127
Creative Planning
Kansas
$4.2M +$663K +9,665 +17%
RHDIC
128
R.H. Dinel Investment Counsel
California
$4.09M +$4.45M +64,900 New
LPL Financial
129
LPL Financial
California
$3.9M +$889K +12,950 +27%
Legal & General Group
130
Legal & General Group
United Kingdom
$3.87M +$349K +5,080 +9%
RJA
131
Raymond James & Associates
Florida
$3.81M -$215K -3,132 -5%
CEP
132
Chicago Equity Partners
Illinois
$3.71M -$299K -4,350 -7%
KCM
133
Kornitzer Capital Management
Kansas
$3.57M -$11.6M -169,703 -75%
HI
134
Handelsinvest Investeringsforvaltning
Denmark
$3.54M
Fisher Asset Management
135
Fisher Asset Management
Washington
$3.51M -$27.5K -400 -0.7%
PI
136
Putnam Investments
Massachusetts
$3.29M
AG
137
Advisor Group
Arizona
$3.28M +$2.17M +31,573 +155%
IA
138
IFG Advisory
Georgia
$3.11M -$260K -3,783 -7%
Group One Trading
139
Group One Trading
Illinois
$2.92M +$152K +2,214 +5%
GAM
140
Gotham Asset Management
New York
$2.78M +$15.2K +221 +0.5%
WCM
141
Wisconsin Capital Management
Wisconsin
$2.63M +$2.86M +41,725 New
SWM
142
SVA Wealth Management
Wisconsin
$2.6M -$13.7K -200 -0.5%
BFM
143
Boston Financial Management
Massachusetts
$2.59M
ACM
144
Aubrey Capital Management
United Kingdom
$2.56M +$1.75M +25,500 +170%
RA
145
RiverPark Advisors
New York
$2.46M -$1.18M -17,186 -31%
RCM
146
Riverhead Capital Management
Delaware
$2.44M -$38.2K -556 -1%
RJFSA
147
Raymond James Financial Services Advisors
Florida
$2.43M +$517K +7,531 +24%
NIM
148
Northeast Investment Management
Massachusetts
$2.4M +$274K +3,998 +12%
Neuberger Berman Group
149
Neuberger Berman Group
New York
$2.33M -$64K -933 -2%
FG
150
Formula Growth
Quebec, Canada
$2.24M

EXAS Hedge Fund Activity: Q4 2018 in Review

370 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q4 2018, worth a combined $7.08B — down 22% from $9.04B a quarter earlier.

Buyers outnumbered sellers: 74 funds opened new EXAS positions and 66 closed out — a net gain of 8 holders — while 93 added to existing stakes and 130 trimmed.

The largest buyer was Viking Global Investors, adding an estimated $183M. The largest seller was Wellington Management Group, cutting an estimated $136M.

  • 370 institutional investors held Exact Sciences (EXAS) as of Q4 2018, up from 365 in Q3 2018.
  • Funds reported $7.08B of Exact Sciences stock for Q4 2018, down 22% quarter-over-quarter.
  • 74 funds opened new Exact Sciences positions in Q4 2018 and 66 closed out, a net change of +8 holders.
  • The largest Exact Sciences buyer in Q4 2018 was Viking Global Investors, an estimated $183M added.
  • The largest Exact Sciences seller in Q4 2018 was Wellington Management Group, an estimated $136M sold.

Based on aggregated 13F filings for Q4 2018.